St. Jude Medical Inc. has announced FDA clearance for its Venture Wire Control Catheter on a rapid exchange delivery platform, a delivery design that accommodates shorter guide wires and may result in quicker, easier coronary procedures.
A unique catheter designed with a deflectable tip that allows interventional cardiologists to treat difficult-to-reach areas of the coronary anatomy, Venture is able to bend 90 degrees. The deflectable tip helps physicians with control and precision when navigating complex turns in the artery, and it provides guide wire support when attempting to access partially blocked vessels.
The original over-the-wire version of Venture was approved in the U.S. and Europe in 2005 — the approval of Venture’s rapid-exchange delivery platform makes the catheter able to accommodate guide wires of any length, including shorter guide wires used more commonly in interventional procedures.
April 03, 2024 
